Fenoldopam |
SK-82526 |
SK&F-82526 |
Corlopam |
67227-56-9 |
DB00800 |
AC1Q3LHG |
CARLACOR |
BIOMOL-NT_000042 |
67227-57-0 |
LS-27993 |
NCGC00025246-02 |
BPBIO1_001265 |
PDSP1_001661 |
FENOLDOPAM (INN) |
NCGC00025246-03 |
6-CHLORO-1-(4-HYDROXYPHENYL)-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE-7,8-DIOL |
FENODOPAM MESYLATE |
67287-54-1 (HYDROBROMIDE) |
3341 |
188303 |
CHEBI:5002 |
DAP000254 |
67227-57-0 (MESYLATE) |
HMS2090G16 |
LOPAC0_000556 |
FENOLDOPAMUM [LATIN] |
NCGC00015444-05 |
9-CHLORO-5-(4-HYDROXYPHENYL)-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE-7,8-DIOL |
L000254 |
CARLACOR (TN) |
UNII-INU8H2KAWG |
C07693 |
87900-90-1 |
PDSP2_001645 |
FENOLDOPAM [INN:BAN] |
1H-3-BENZAZEPINE-7,8-DIOL, 6-CHLORO-2,3,4,5-TETRAHYDRO-1-(4-HYDROXYPHENYL)- |
AR-1L4264 |
AC1L1FPQ |
D07946 |
CID3341 |
BRD-A50684349-001-01-5 |
FENOLDOPAMUM |
135651054 |
939 |
9-CHLORO-5-(4-HYDROXYPHENYL)-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE-7,8-DIOL;METHANESULFONIC ACID |
9-CHLORANYL-5-(4-HYDROXYPHENYL)-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE-7,8-DIOL;METHANESULFONIC ACID |
9-CHLORO-5-(4-HYDROXYPHENYL)-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE-7,8-DIOL;MESYLIC ACID |
AB00698256-15 |
AB00698256-13 |
FT-0641107 |
AB2000493 |
AB0013872 |
I745 |
BC220528 |
AN-38412 |
NCGC00015444-07 |
NCGC00015444-06 |
NCGC00015444-03 |
VA10891 |
MCULE-7876003953 |
CS-2979 |
CCG-204646 |
TOX21_110152_1 |
AKOS015906543 |
TOX21_110152 |
HY-B0735 |
BDBM60917 |
SCHEMBL13287212 |
CID_49659 |
GTPL939 |
SCHEMBL34250 |
CORLOPAMREG |
SMR000469190 |
SK-82526-J |
CAS-67227-56-9 |
MLS001401388 |
DSSTOX_GSID_43896 |
DSSTOX_RID_80083 |
DSSTOX_CID_23896 |
NCGC00015444-04 |
TVURRHSHRRELCG-UHFFFAOYSA-N |
Drug Categories | vasodilator agents |
Drug Categories | therapeutic uses |
Drug Categories | physiological effects of drugs |
Drug Categories | pharmacologic actions |
Drug Categories | neurotransmitter agents |
Drug Categories | molecular mechanisms of pharmacological action |
Drug Categories | hypotensive agents |
Drug Categories | heterocyclic compounds, 2-ring |
Drug Categories | heterocyclic compounds |
Drug Categories | dopamine agonists |
Drug Categories | dopamine agents |
Drug Categories | chemical actions and uses |
Drug Categories | cardiovascular system |
Drug Categories | cardiovascular agents |
Drug Categories | cardiac therapy |
Drug Categories | cardiac stimulants excl. cardiac glycosides |
Drug Categories | benzazepines |
Drug Categories | antihypertensive agents |
Drug Categories | adrenergic and dopaminergic agents |
Drug Groups | approved |
Drug Type | small molecule |
Drug Class | antihypertensive agents |
Year of Approval | 1997 |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | antihypertensive agent |
agonist |
Specific Action of the Ligand | Full agonist |
Endogenous Drug? | False |
Direct Interaction? | True |
agonist |
Specific Action of the Ligand | Full agonist |
Endogenous Drug? | False |
agonist |
Trial Name | fenoldopam mesylate, SKF-82526,Corlopam |
Novel drug target | Established target |
antagonist |
antagonist |
antagonist |
n/a |
n/a |
n/a |
FENOLDOPAM | DrugBank Drug Name |
67227-56-9 | CAS Number |
Corlopam | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Categories | adrenergic and dopaminergic agents |
FENOLDOPAM | Primary Drug Name |
Year of Approval | 1997 |
Drug Class | antihypertensive agents |
Drug Indications | antihypertensive agent |
Drug Class | Small Molecule |
FDA Approval | approved |
FENOLDOPAMUM | Drug Synonym |
BRD-A50684349-001-01-5 | Drug Synonym |
DB00800 | Drug Synonym |
FENOLDOPAM | GuideToPharmacology Ligand Name |
135651054 | PubChem Drug SID |
FENOLDOPAM | pubchem_primary_name |
3341 | PubChem CID |
FENOLDOPAMUM | Drug Synonym |